Clinical trial
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study With an Open Label Extension to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Axial Spondyloarthritis
NCT02985983 is registered in ClinicalTrials.gov with Kyowa Kirin Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study With an Open Label Extension to Evaluate the Efficacy and Safety of Brodalumab in Subjects With Axial Spondyloarthritis
- Lead sponsor
- Kyowa Kirin Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 7, 2017
- Completion date
- September 23, 2019
- Enrollment
- 159 (actual)
- Sites
- 48
Conditions
As the registry lists them; a condition with its own page is linked.